2013 -- H 5063 | |
======= | |
LC00046 | |
======= | |
STATE OF RHODE ISLAND | |
| |
IN GENERAL ASSEMBLY | |
| |
JANUARY SESSION, A.D. 2013 | |
| |
____________ | |
| |
A N A C T | |
RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCE ACT | |
|
      |
|
      |
     Introduced By: Representatives Corvese, McNamara, O'Brien, Azzinaro, and Malik | |
     Date Introduced: January 10, 2013 | |
     Referred To: House Judiciary | |
It is enacted by the General Assembly as follows: | |
1-1 |
     SECTION 1. Section 21-28-2.0.8 of the General Laws in Chapter 21-28 entitled |
1-2 |
"Uniform Controlled Substances Act" is hereby amended to read as follows: |
1-3 |
     21-28-2.08. Contents of schedules. -- Schedule I |
1-4 |
      (a) Schedule I shall consist of the drugs and other substances, by whatever official name, |
1-5 |
common or usual name, chemical name, or brand name designated, listed in this section. |
1-6 |
      (b) Opiates. - Unless specifically excepted or unless listed in another schedule, any of |
1-7 |
the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and |
1-8 |
ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the |
1-9 |
specific chemical designation: |
1-10 |
      (1) Acetylmethadol |
1-11 |
      (2) Allylprodine |
1-12 |
      (3) Alphacetylmethadol |
1-13 |
      (4) Alphameprodine |
1-14 |
      (5) Alphamethadol |
1-15 |
      (6) Benzethidine |
1-16 |
      (7) Betacetylmethadol |
1-17 |
      (8) Betameprodine |
1-18 |
      (9) Betamethadol |
1-19 |
      (10) Betaprodine |
2-20 |
      (11) Clonitazene |
2-21 |
      (12) Dextromoramide |
2-22 |
      (13) Difenoxin |
2-23 |
      (14) Diampromide |
2-24 |
      (15) Diethylthiambutene |
2-25 |
      (16) Dimenoxadol |
2-26 |
      (17) Dimepheptanol |
2-27 |
      (18) Dimethylthiambutene |
2-28 |
      (19) Dioxaphetyl butyrate |
2-29 |
      (20) Dipipanone |
2-30 |
      (21) Ethylmethylthiambutene |
2-31 |
      (22) Etonitazene |
2-32 |
      (23) Extoxerdine |
2-33 |
      (24) Furethidine |
2-34 |
      (25) Hydroxypethidine |
2-35 |
      (26) Ketobemidone |
2-36 |
      (27) Levomoramide |
2-37 |
      (28) Levophenacylmorphan |
2-38 |
      (29) Morpheridine |
2-39 |
      (30) Noracymethadol |
2-40 |
      (31) Norlevorphanol |
2-41 |
      (32) Normethadone |
2-42 |
      (33) Norpipanone |
2-43 |
      (34) Phenadoxone |
2-44 |
      (35) Phenampromide |
2-45 |
      (36) Phenomorphan |
2-46 |
      (37) Phenoperidine |
2-47 |
      (38) Piritramide |
2-48 |
      (39) Proheptazine |
2-49 |
      (40) Properidine |
2-50 |
      (41) Propiram |
2-51 |
      (42) Racemoramide |
2-52 |
      (43) Trimeperidone |
2-53 |
      (44) Tilidine |
3-54 |
      (45) Alpha-methylfentanyl |
3-55 |
      (46) Beta-hydroxy-3-methylfentanyl other names: |
3-56 |
      N-[1-(2hydroxy-2-phenethyl)-3-methyl-4piperidingyl] Nphenylpropanamide |
3-57 |
      (c) Opium Derivatives. - Unless specifically excepted or unless listed in another |
3-58 |
schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever |
3-59 |
the existence of the salts, isomers, and salts of isomers is possible within the specific chemical |
3-60 |
designation: |
3-61 |
      (1) Acetorphine |
3-62 |
      (2) Acetyldihydrocodeine |
3-63 |
      (3) Benzylmorphine |
3-64 |
      (4) Codeine methylbromide |
3-65 |
      (5) Codeine-N-Oxide |
3-66 |
      (6) Cyprenorphine |
3-67 |
      (7) Desomorphine |
3-68 |
      (8) Dihydromorphine |
3-69 |
      (9) Etorphine (Except hydrochloride salt) |
3-70 |
      (10) Heroin |
3-71 |
      (11) Hydromorphinol |
3-72 |
      (12) Methyldesorphine |
3-73 |
      (13) Methylihydromorphine |
3-74 |
      (14) Morphine methylbromide |
3-75 |
      (15) Morphine methylsulfonate |
3-76 |
      (16) Morphine-N-Oxide |
3-77 |
      (17) Myrophine |
3-78 |
      (18) Nococodeine |
3-79 |
      (19) Nicomorphine |
3-80 |
      (20) Normorphine |
3-81 |
      (21) Pholcodine |
3-82 |
      (22) Thebacon |
3-83 |
      (23) Drotebanol |
3-84 |
      (d) Hallucinogenic Substances. - Unless specifically excepted or unless listed in another |
3-85 |
schedule, any material, compound, mixture, or preparation, which contains any quantity of the |
3-86 |
following hallucinogenic substances, or which contains any of its salts, isomers, and salts of |
3-87 |
isomers whenever the existence of the salts, isomers, and salts of isomers is possible within the |
3-88 |
specific chemical designation (for purposes of this subsection only, the term "isomer" includes |
4-1 |
the optical, position, and geometric isomers): |
4-2 |
      (1) 3, 4-methylenedioxy amphetamine |
4-3 |
      (2) 5-methoxy-3, 4-methylenedioxy amphetamine |
4-4 |
      (3) 3, 4, 5-trimethoxy amphetamine |
4-5 |
      (4) Bufotenine |
4-6 |
      (5) Diethyltryptamine |
4-7 |
      (6) Dimethyltryptamine |
4-8 |
      (7) 4-methyl 2, 5-dimethoxyamphetamine |
4-9 |
      (8) Ibogaine |
4-10 |
      (9) Lysergic acid diethylamide |
4-11 |
      (10) Marihuana |
4-12 |
      (11) Mescaline |
4-13 |
      (12) Peyote. Meaning all parts of the plant presently classified botanically as |
4-14 |
Lophophora Williamsii Lemair whether growing or not; the seeds of the plant; any extract from |
4-15 |
any part of the plant; and any compound, manufacture, salt, derivative, mixture, or preparation of |
4-16 |
the plant, its seeds or extracts. |
4-17 |
      (13) N-ethyl-3-piperidyl benzilate |
4-18 |
      (14) N-methyl-3-piperidyl benzilate |
4-19 |
      (15) Psilocybin |
4-20 |
      (16) Psilocyn |
4-21 |
      (17) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the |
4-22 |
plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and |
4-23 |
their isomers with similar chemical structure and pharmacological activity such as the following: |
4-24 |
delta 1 cis or trans tetrahydrocannabinol, and their optical isomers. Delta 6 cis or trans |
4-25 |
tetrahydrocannabinol and their optical isomers. Delta 3, 4 cis or trans tetrahydrocannabinol and |
4-26 |
its optical isomer. (Since nomenclature of these substances is not internationally standardized, |
4-27 |
compounds of these structures, regardless of numerical designation of atomic positions covered). |
4-28 |
      (18) Thiophene analog of phencyclidine. 1-(1-(2 thienyl) cyclo-hexyl) pipiridine: 2- |
4-29 |
Thienyl analog of phencyclidine: TPCP |
4-30 |
      (19) 2,5 dimethoxyamphetamine |
4-31 |
      (20) 4-bromo-2,5-dimethoxyamphetamine, 4-bromo-2,5-dimethoxy-alpha- |
4-32 |
methylphenethyamine: 4-bromo-2,5-DMA |
4-33 |
      (21) 4-methoxyamphetamine-4-methoxy-alpha-methylphenethylaimine: |
4-34 |
paramethoxyamphetamine: PMA |
5-1 |
      (22) Ethylamine analog of phencyclidine. N-ethyl-1- phenylcyclohexylamine, (1- |
5-2 |
phenylcyclohexyl) ethylamine, N-(1-phenylcyclophexyl) ethylamine, cyclohexamine, PCE |
5-3 |
      (23) Pyrrolidine analog of phencyclidine. 1-(1-phencyclohexyl)- pyrrolidine PCPy, PHP |
5-4 |
      (24) Parahexyl; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro- |
5-5 |
6,6,9-trimethyl-6H-dibenz o (b,d) pyran: Synhexyl. |
5-6 |
      (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any |
5-7 |
material, compound, mixture, or preparation which contains any quantity of the following |
5-8 |
substances having a depressant effect on the central nervous system, including its salts, isomers, |
5-9 |
and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible |
5-10 |
within the specific chemical designation: |
5-11 |
      (1) Mecloqualone. |
5-12 |
      (2) Methaqualone. |
5-13 |
      (3) 3-methyl fentanyl (n-( ethyl-1(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide. |
5-14 |
      (4) 3,4-methyl-enedioxymethamphetamine (MDMA), its optical, positional and |
5-15 |
geometric isomers, salts, and salts of isomers. |
5-16 |
      (5) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical isomers, salts and |
5-17 |
salts of isomers. |
5-18 |
      (6) 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (PEPAP), its optical isomers, salts |
5-19 |
and salts of isomers. |
5-20 |
      (7) N-(1-(1-methyl-2-phenyl)ethyl-4-piperidyl)-N-phenyl-acetamide (acetyl-alpha- |
5-21 |
methylfentanyl), its optical isomers, salts and salts of isomers. |
5-22 |
      (8) N-(1-(1-methyl-2(2-thienyl)ethyl-4-piperidyl)-N-phenylpropanami de (alpha- |
5-23 |
methylthiofentanyl), its optical isomers, salts and salts of isomers. |
5-24 |
      (9) N-(1-benzyl-piperidyl)-N-phenylpropanamide (benzyl-fentanyl), its optical isomers, |
5-25 |
salts and salts of isomers. |
5-26 |
      (10) N-(1-(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenyl-propanamid e (beta- |
5-27 |
hydroxyfentanyl), its optical isomers, salts and salts of isomers. |
5-28 |
      (11) N-(3-methyl-1(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenylpro panamide (beta- |
5-29 |
hydroxy-3-methylfentanyl), its optical and geometric isomers, salts and salts of isomers. |
5-30 |
      (12) N-(3-methyl)-1-(2-(2-thienyl)ethyl-4-piperidyl)-N-phenylpro- panamide (3- |
5-31 |
methylthiofentanyl), its optical and geometric isomers, salts and salts of isomers. |
5-32 |
      (13) N-(1-2-thienyl)methyl-4-piperidyl)-N-phenylpropanamide (thenylfentanyl), its |
5-33 |
optical isomers, salts and salts of isomers. |
6-34 |
      (14) N-(1-(2(2-thienyl)ethyl-4-piperidyl-N-phenylpropanamide (thiofentanyl), its optical |
6-35 |
isomers, salts and salts of isomers. |
6-36 |
      (15) N-[1-(2-phenylethyl)-4-piperidyl]N-(4-fluorophenyl)-propanamid e (para- |
6-37 |
fluorofentanyl), its optical isomers, salts and salts of isomers. |
6-38 |
      (16) Gamma hydroxybutyrate, HOOC-CH2-CH2-CH2OH, its optical, position, or |
6-39 |
geometric isomers, salts and salts of isomers. |
6-40 |
     (17) Salvia Divinorum (Salvinorin A or Divinorin A). |
6-41 |
     (18) Datura stamonium (gypsum weed or jimsom weed). |
6-42 |
     (19) Synthetic cannabinoids (synthetic marijuana). |
6-43 |
      (f) Stimulants. - Unless specifically excepted or unless listed in another schedule, any |
6-44 |
material, compound, mixture, or preparation which contains any quantity of the following |
6-45 |
substances having a stimulant effect on the central nervous system, including its salts, isomers, |
6-46 |
and salts of isomers: |
6-47 |
      (1) Fenethylline |
6-48 |
      (2) N-ethylamphetamine |
6-49 |
      (3) 4-methyl-N-methylcathinone (Other name: mephedrone) |
6-50 |
      (4) 3,4-methylenedioxy-N-methlycathinone (Other name: methylone) |
6-51 |
      (5) 3,4-methylenedioxypyrovalerone (Other name: MDPV) |
6-52 |
      (g) Any material, compound, mixture or preparation which contains any quantity of the |
6-53 |
following substances: |
6-54 |
      (1) 5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]phenol (CP-47,497) |
6-55 |
      (2) 5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]phenol |
6-56 |
(cannabicyclohexanol and CP-47,497 c8 homologue) |
6-57 |
      (3) 1-Butyl-3-(1 naphthoyl)indole, (JWH-073) |
6-58 |
      (4) 1-[2-(4-Morpholinyl)ethyl]3-(1-naphthoyl)indole (JWH-200) |
6-59 |
      (5) 1-Pentyl-3-(1-napthoyl)indole, (JWH-018 and AM678) |
6-60 |
      Schedule II |
6-61 |
      (a) Schedule II shall consist of the drugs and other substances, by whatever official |
6-62 |
name, common or usual name, chemical name, or brand name designated, listed in this section. |
6-63 |
      (b) Substances, vegetable origin or chemical synthesis. - Unless specifically excepted or |
6-64 |
unless listed in another schedule, any of the following substances whether produced directly or |
6-65 |
indirectly by extraction from substances of vegetable origin, or independently by means of |
6-66 |
chemical synthesis, or by a combination of extraction and chemical synthesis: |
6-67 |
      (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or |
6-68 |
opiate excluding naloxone and its salts, and excluding naltrexone and its salts, but including the |
7-1 |
following: |
7-2 |
      (i) Raw opium |
7-3 |
      (ii) Opium extracts |
7-4 |
      (iii) Opium fluid extracts |
7-5 |
      (iv) Powdered opium |
7-6 |
      (v) Granulated opium |
7-7 |
      (vi) Tincture of opium |
7-8 |
      (vii) Etorphine hydrochloride |
7-9 |
      (viii) Codeine |
7-10 |
      (ix) Ethylmorphine |
7-11 |
      (x) Hydrocodone |
7-12 |
      (xi) Hydromorphone |
7-13 |
      (xii) Metopon |
7-14 |
      (xiii) Morphine |
7-15 |
      (xiv) Oxycodone |
7-16 |
      (xv) Oxymorphone |
7-17 |
      (xvi) Thebaine |
7-18 |
      (2) Any salt, compound, derivative, or preparation which is chemically equivalent or |
7-19 |
identical with any of the substances referred to in subdivision (1) of this subsection, except that |
7-20 |
these substances shall not include the isoquinoline alkaloids of opium. |
7-21 |
      (3) Opium poppy and poppy straw. |
7-22 |
      (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and |
7-23 |
any salt, compound, derivative, or preparation which is chemically equivalent or identical with |
7-24 |
any of these substances, except that the substances shall not include decocainized coca leaves or |
7-25 |
extraction of coca leaves, which extractions do not contain cocaine or ecgonine. |
7-26 |
      (5) Concentrate of poppy straw (the crude extract of poppy straw in liquid, solid, or |
7-27 |
powder form which contains the phenanthrine alkaloids of the opium poppy). |
7-28 |
      (c) Opiates. - Unless specifically excepted or unless listed in another schedule any of the |
7-29 |
following opiates, including its isomers, esters, ethers, salts; and salts of isomers, esters and, |
7-30 |
ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the |
7-31 |
specific chemical designation: |
7-32 |
      (1) Alphaprodine |
7-33 |
      (2) Anileridine |
8-34 |
      (3) Bezitramide |
8-35 |
      (4) Dihydrocodeine |
8-36 |
      (5) Diphenoxylate |
8-37 |
      (6) Fentanyl |
8-38 |
      (7) Isomethadone |
8-39 |
      (8) Levomethorphan |
8-40 |
      (9) Levorphanol |
8-41 |
      (10) Metazocine |
8-42 |
      (11) Methadone |
8-43 |
      (12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane |
8-44 |
      (13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic |
8-45 |
acid |
8-46 |
      (14) Pethidine |
8-47 |
      (15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine |
8-48 |
      (16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate |
8-49 |
      (17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid |
8-50 |
      (18) Phenaxocine |
8-51 |
      (19) Piminodine |
8-52 |
      (20) Racemethorphan |
8-53 |
      (21) Racemorphan |
8-54 |
      (22) Bulk Dextropropoxyphene (non-dosage forms) |
8-55 |
      (23) Suffentanil |
8-56 |
      (24) Alfentanil |
8-57 |
      (25) Levoalphacetylmethadol |
8-58 |
      (d) Stimulants. - Unless specifically excepted or unless listed in another schedule, any |
8-59 |
material, compound, mixture, or preparation which contains any quantity of the following |
8-60 |
substances having a stimulant effect on the central nervous system: |
8-61 |
      (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers. |
8-62 |
      (2) Methamphetamine, its salts and salts of its isomers. |
8-63 |
      (3) Phenmetrazine and its salts. |
8-64 |
      (4) Methylphenidate. |
8-65 |
      (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any |
8-66 |
material, compound, mixture, or preparation which contains any quantity of the following |
8-67 |
substances having a depressant effect on the central nervous system, including its salts, isomers, |
8-68 |
and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible |
9-1 |
within the specific chemical designation: |
9-2 |
      (1) Amobarbital |
9-3 |
      (2) Glutethimide |
9-4 |
      (3) Methyprylon |
9-5 |
      (4) Pentobarbital |
9-6 |
      (5) Phencyclidine |
9-7 |
      (6) Secobarbital |
9-8 |
      (7) Phencyclidine immediate precursors: |
9-9 |
      (i) 1-phencyclohexylamine |
9-10 |
      (ii) 1-piperidinocyclohexane-carbonitrile (PCC) |
9-11 |
      (8) Immediate precursor to amphetamine and methamphetamine: Phenylacetone. Some |
9-12 |
other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzone ketone. |
9-13 |
      Schedule III |
9-14 |
      (a) Unless specifically excepted or unless listed in another schedule, any material, |
9-15 |
compound, mixture, or preparation which contains any quantity of the following substances |
9-16 |
having a depressant effect on the central nervous system: |
9-17 |
      (1) Any substance which contains any quantity of a derivative of barbituric acid, or any |
9-18 |
salt of a derivative of barbituric acid. |
9-19 |
      (2) Chlorhexadol |
9-20 |
      (3) Lysergic acid |
9-21 |
      (4) Lysergic acid amide |
9-22 |
      (5) Sulfondiethylmethane |
9-23 |
      (6) Sulfonethylmethane |
9-24 |
      (7) Sylfonmethane |
9-25 |
      (8) Any compound, mixture, or preparation containing amobarbital, secobarbital, |
9-26 |
pentobarbital, or any salt of them and one or more other active medicinal ingredients which are |
9-27 |
not listed in any schedule. |
9-28 |
      (9) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital or |
9-29 |
any salt of any of these drugs and approved by the Food and Drug Administration for marketing |
9-30 |
only as a suppository. |
9-31 |
      (10) Ketamine, its salts, isomers and salts of isomers. (Some other names for ketamine: |
9-32 |
(+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone). |
9-33 |
      (b) Unless specifically excepted or unless listed in another schedule, any material, |
9-34 |
compound, mixture, or preparation containing limited quantities of any of the following narcotic |
10-1 |
drugs, or any salts of them: |
10-2 |
      (1) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred |
10-3 |
milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with an equal |
10-4 |
or greater quantity of an isoquinoline alkaloid of opium. |
10-5 |
      (2) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred |
10-6 |
milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or |
10-7 |
more active, nonnarcotic ingredients in recognized therapeutic amounts. |
10-8 |
      (3) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one |
10-9 |
hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with |
10-10 |
a fourfold or greater quantity of an isoquinoline alkaloid of opium. |
10-11 |
      (4) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one |
10-12 |
hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with |
10-13 |
one or more active nonnarcotic ingredients in recognized therapeutic amounts. |
10-14 |
      (5) Not more than one and eight tenths grams (1.8 gms.) of dihydrocodeine per one |
10-15 |
hundred milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with |
10-16 |
one or more active nonnarcotic ingredients in recognized therapeutic amounts. |
10-17 |
      (6) Not more than three hundred milligrams (300 mgs.) of ethylmorphine per one |
10-18 |
hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with |
10-19 |
one or more active nonnarcotic ingredients in recognized therapeutic amounts. |
10-20 |
      (7) Not more than five hundred milligrams (500 mgs.) of opium per one hundred |
10-21 |
milliliters (100 mls.) or per one hundred grams (100 gms.) or not more than twenty-five |
10-22 |
milligrams (25 mgs.) per dosage unit, with one or more active nonnarcotic ingredients in |
10-23 |
recognized therapeutic amounts. |
10-24 |
      (8) Not more than fifty milligrams (50 mgs.) of morphine per one hundred milliliters |
10-25 |
(100 mls.) per one hundred grams (100 gms.) with one or more active, nonnarcotic ingredients in |
10-26 |
recognized therapeutic amounts. |
10-27 |
      (c) Stimulants. - Unless specifically excepted or listed in another schedule, any material, |
10-28 |
compound, mixture, or preparation which contains any quantity of the following substances |
10-29 |
having a stimulant effect on the central nervous system, including its salts, isomers, and salts of |
10-30 |
the isomers whenever the existence of the salts of isomers is possible within the specific chemical |
10-31 |
designation: |
10-32 |
      (1) Benzphetamine |
10-33 |
      (2) Chlorphentermine |
11-34 |
      (3) Clortermine |
11-35 |
      (4) Mazindol |
11-36 |
      (5) Phendimetrazine |
11-37 |
      (d) Steroids and hormones. - Anabolic steroids (AS) or human growth hormone (HGH), |
11-38 |
excluding those compounds, mixtures, or preparations containing an anabolic steroid that because |
11-39 |
of its concentration, preparation, mixture or delivery system, has no significant potential for |
11-40 |
abuse, as published in 21 CFR 1308.34, including, but not limited to, the following: |
11-41 |
      (1) Chlorionic gonadotropin |
11-42 |
      (2) Clostebol |
11-43 |
      (3) Dehydrochlormethyltestosterone |
11-44 |
      (4) Ethylestrenol |
11-45 |
      (5) Fluoxymesterone |
11-46 |
      (6) Mesterolone |
11-47 |
      (7) Metenolone |
11-48 |
      (8) Methandienone |
11-49 |
      (9) Methandrostenolone |
11-50 |
      (10) Methyltestosterone |
11-51 |
      (11) Nandrolone decanoate |
11-52 |
      (12) Nandrolone phenpropionate |
11-53 |
      (13) Norethandrolone |
11-54 |
      (14) Oxandrolone |
11-55 |
      (15) Oxymesterone |
11-56 |
      (16) Oxymetholone |
11-57 |
      (17) Stanozolol |
11-58 |
      (18) Testosterone propionate |
11-59 |
      (19) Testosterone-like related compounds |
11-60 |
      (20) Human Growth Hormone (HGH) |
11-61 |
      (e) Hallucinogenic substances. |
11-62 |
      (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in |
11-63 |
U.S. Food and Drug Administration approved drug product. (Some other names for dronabinol: |
11-64 |
(6aR-trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9- trimethyl-3-pentyl-6H- dibenzo[b,d]yra n-1-ol,or(-)- |
11-65 |
delta-9(trans)-tetrahydrocannabinol.) |
11-66 |
      Schedule IV |
11-67 |
      (1) Barbital. |
12-68 |
      (2) Chloral betaine |
12-69 |
      (3) Chloral hydrate |
12-70 |
      (4) Ethchrovynol |
12-71 |
      (5) Ethinamate |
12-72 |
      (6) Methohexital |
12-73 |
      (7) Meprobamate |
12-74 |
      (8) Methylphenobarbital |
12-75 |
      (9) Paraldehyde |
12-76 |
      (10) Petrichloral |
12-77 |
      (11) Phenobarbital |
12-78 |
      (12) Fenfluramine |
12-79 |
      (13) Diethylpropion |
12-80 |
      (14) Phentermine |
12-81 |
      (15) Pemoline (including organometallic complexes and chelates thereof). |
12-82 |
      (16) Chlordiazepoxide |
12-83 |
      (17) Clonazepam |
12-84 |
      (18) Clorazepate |
12-85 |
      (19) Diazepam |
12-86 |
      (20) Flurazepam |
12-87 |
      (21) Mebutamate |
12-88 |
      (22) Oxazepam |
12-89 |
      (23) Unless specifically excepted or unless listed in another schedule, any material, |
12-90 |
compound, mixture, or preparation which contains any quantity of the following substances, |
12-91 |
including its salts: |
12-92 |
      Dextropropoxyphene(alpha-(+)-4-dimethylamino-1,2-diphenyl-3- methyl-2- |
12-93 |
propronoxybutane). |
12-94 |
      (24) Prazepam |
12-95 |
      (25) Lorazepam |
12-96 |
      (26) Not more than one milligram (1 mg.) of difenoxin and not less than twenty-five (25) |
12-97 |
micrograms of atropine sulfate per dosage unit. |
12-98 |
      (27) Pentazocine |
12-99 |
      (28) Pipradrol |
12-100 |
      (29) SPA (-)-1-dimethylamino-1, 2-diphenylethane |
12-101 |
      (30) Temazepam |
13-102 |
      (31) Halazepam |
13-103 |
      (32) Alprazolam |
13-104 |
      (33) Bromazepam |
13-105 |
      (34) Camazepam |
13-106 |
      (35) Clobazam |
13-107 |
      (36) Clotiazepam |
13-108 |
      (37) Cloxazolam |
13-109 |
      (38) Delorazepam |
13-110 |
      (39) Estazolam |
13-111 |
      (40) Ethyl Ioflazepate |
13-112 |
      (41) Fludizaepam |
13-113 |
      (42) Flunitrazepam |
13-114 |
      (43) Haloxazolam |
13-115 |
      (44) Ketazolam |
13-116 |
      (45) Loprazolam |
13-117 |
      (46) Lormetazepam |
13-118 |
      (47) Medazepam |
13-119 |
      (48) Nimetazepam |
13-120 |
      (49) Nitrazepam |
13-121 |
      (50) Nordiazepam |
13-122 |
      (51) Oxazolam |
13-123 |
      (52) Pinazepam |
13-124 |
      (53) Tetrazepam |
13-125 |
      (54) Mazindol |
13-126 |
      (55) Triazolam |
13-127 |
      (56) Midazolam |
13-128 |
      (57) Quazepam |
13-129 |
      (58) Butorphanol |
13-130 |
      (59) Sibutramine |
13-131 |
      Schedule V |
13-132 |
      (a) Any compound, mixture, or preparation containing any of the following limited |
13-133 |
quantities of narcotic drugs, which shall include one or more non-narcotic active medicinal |
13-134 |
ingredients in sufficient proportion to confer upon the compound, mixture, or preparation |
13-135 |
valuable medicinal qualities other than those possessed by the narcotic drug alone: |
14-136 |
      (1) Not more than two hundred milligrams (200 mgs.) of codeine per 100 milliliters (100 |
14-137 |
mls.) or per one hundred grams (100 gms.). |
14-138 |
      (2) Not more than one hundred milligrams (100 mgs.) of dihydrocodeine per 100 |
14-139 |
milliliters (100 mls.) or per one hundred grams (100 gms.). |
14-140 |
      (3) Not more than one hundred milligrams (100 mgs.) of ethylmorphine per 100 |
14-141 |
milliliters (100 mls.) or per one hundred grams (100 gms.). |
14-142 |
      (4) Not more than two and five tenths milligrams (2.5 mgs.) of diphenixylate and not less |
14-143 |
than twenty-five (25) micrograms of atropine sulfate per dosage unit. |
14-144 |
      (5) Not more than one hundred milligrams (100 mgs.) of opium per one hundred |
14-145 |
milliliters (100 mls.) or per one hundred grams (100 gms.). |
14-146 |
      (b) Not more than five tenths milligrams (0.5 mgs.) of difenoxin and not less than |
14-147 |
twenty-five (25) micrograms of atropine sulfate per dosage unit. |
14-148 |
      (c) Buprenorphine |
14-149 |
      (d) Unless specifically exempted or excluded or unless listed in another schedule, any |
14-150 |
material, compound, mixture, or preparation which contains any quantity of the following |
14-151 |
substances having a stimulant effect on the central nervous system, including its salts, isomers |
14-152 |
and salts of isomers: |
14-153 |
      (1) Propylhexedrine (except as benzedrex inhaler) |
14-154 |
      (2) Pyrovalerone. |
14-155 |
     SECTION 2. This act shall take effect upon passage. |
      | |
======= | |
LC00046 | |
======= | |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCE ACT | |
*** | |
15-1 |
     This act would add the hallucinogenic drugs Salvia Divinorum (Salvinorin A or |
15-2 |
Divinorin A), Datura stramonmium (gypsum weed or jimsom weed) and synthetic cannabinoids |
15-3 |
(synthetic marijuana) to the Rhode Island Controlled Substances Act Schedule 1, the misuse of |
15-4 |
which may result in the requisite criminal penalties for abuse. |
15-5 |
     This act would take effect upon passage. |
      | |
======= | |
LC00046 | |
======= |